Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Osaka University Graduate School of Medicine | UNKNOWN |
Not provided
Not provided
Not provided
The objective of this study is to construct a registry; in order to understand the onset status of triglyceride deposit cardiomyovasculopathy (TGCV) in Japan with patients' background and natural history of the disease, and to explore disease-specific prognostic factors.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| TGCV | Patients who have been confirmed as TGCV by a cardiologist. |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| The period between the date of TGCV diagnosis and the date of death due to any cause | The period is from the date of diagnosis of TGCV to the date of death due to any cause. Survival and lost follow-up cases will be censored on the final confirmation date of survival. | 10 years |
| Measure | Description | Time Frame |
|---|---|---|
| Comparison of subjective symptoms, laboratory findings, and event occurrence before and after tricaprin therapy: Washout rate of BMIPP (%) | 10 years | |
| Comparison of subjective symptoms, laboratory findings, and event occurrence before and after tricaprin therapy: LVEF (%) (UCG or QGS) |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Adult patients (excluding under 20 years old) who have been confirmed as TGCV based on the diagnostic criteria for TGCV by a cardiologist.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Ken-ichi Hirano, MD, PhD | Department of Triglyceride Science, Graduate School of Medicine, Osaka University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Aichi Medical University | Nagakute | Aichi-ken | 4801195 | Japan | ||
| Nagoya University |
Not provided
Not provided
Not provided
Not provided
| 10 years |
| Comparison of subjective symptoms, laboratory findings, and event occurrence before and after tricaprin therapy: Any cardiovascular events | 10 years |
| Presence (date of occurrence or treatment) or absence of various events | To measure the period from the date of diagnosis of TGCV to the date the following event occurs: non-fatal myocardial infarction by the outcome assessment, non-fatal stroke, hospitalization for heart failure, CABG, PCI, TVR, pacemaker/ICD implantation, CRT, VAD, acute coronary syndrome requiring hospitalization, hospitalization/device activation/heart transplantation due to fatal arrhythmia. However, surgery scheduled at the time of diagnosis will not be treated as an event. | 10 years |
| Nagoya |
| Aichi-ken |
| 4668560 |
| Japan |
| Chiba University Graduate School of Medicine | Chiba | Chiba | 2608677 | Japan |
| Kyushu University | Fukuoka | Fukuoka | 8128582 | Japan |
| Hyogo Medical University | Nishinomiya | Hyōgo | 6638501 | Japan |
| Osaka University Hospital | Suita | Osaka | 5650871 | Japan |
| Juntendo University | Bunkyo | Tokyo | 1138431 | Japan |